Quality improvement for stroke management at the Cleveland Clinic Health System.
BACKGROUND
The Cleveland Clinic Health System established a stroke quality improvement (QI) initiative across its nine hospitals. IMPLEMENTING THE STROKE QI INITIATIVE: A stroke QI team took a three-pronged approach to QI: professional education, public education, and hospital process improvements. Its activities and subsequent data analysis needs were divided into four cycles (1999-2003). All data were provided to the stroke QI team and then to the Medical Operations Council to review results, consider data integrity issues, and plan dissemination. The dissemination of performance results permitted broad organizational responses to facilitate improvement. Improvement activities included professional education, public awareness, process improvement, focused data collection with routine feedback, protocol refinement, and coordination of clinical personnel within and between hospitals.


RESULTS
The frequency of brain hemorrhagic complications decreased by more than half, from 13.4% to 6.4%; the rate of intravenous tissue plasminogen activator use increased from 1.5% to 3.9% of all stroke patients; and protocol deviations were reduced from 33% to 17%.


CONCLUSIONS
The keys to this initiative's success were the health system's leadership's support, physicians' engagement via multidisciplinary project committees at the health system and hospital levels, and flexibility in implementing locally tailored process interventions.
Hixson
Eric D
ED
Measurement Services, The Quality Institute, Cleveland Clinic Health System, Cleveland, USA. hixsone@ccf.org
Nadzam
Deborah M
DM
Katzan
Irene L
IL
Furlan
Anthony J
AJ
D006801:Humans; D007262:Infusions, Intravenous; D009096:Multi-Institutional Systems; D009820:Ohio; D019982:Organizational Case Studies; D010960:Plasminogen Activators / Q000627:therapeutic use; D015397:Program Evaluation; D011785:Quality Assurance, Health Care / Q000458:organization & administration*; D017751:Safety Management; D020521:Stroke / Q000628:therapy*
D010960:Plasminogen Activators